Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
1.
Arch. endocrinol. metab. (Online) ; 60(6): 582-586, Nov.-Dec. 2016. tab, graf
Article Dans Anglais | LILACS | ID: biblio-827786

Résumé

ABSTRACT Objective The current study was aimed at analyzing sarcoplasmic reticulum Ca2+ ATPase (Serca2) and ryanodine receptor type 2 (Ryr2) gene expression in rats subjected to surgery that induced HF and were subsequently treated with T4 using physiological doses. Materials and methods HF was induced in 18 male Wistar rats by clipping the ascending thoracic aorta to generate aortic stenosis (HFS group), while the control group (9-sham) underwent thoracotomy. After 21 weeks, the HFS group was subdivided into two subgroups. One group (9 Wistar rats) with HF received 1.0 µg of T4/100 g of body weight for five consecutive days (HFS/T4); the other group (9 Wistar rats) received isotonic saline solution (HFS/S). The animals were sacrificed after this treatment and examined for signs of HF. Samples from the left ventricles of these animals were analyzed by RT-qPCR for the expression of Serca2 and Ryr2 genes. Results Rats with HF developed euthyroid sick syndrome (ESS) and treatment with T4 restored the T3 values to the Sham level and increased Serca2 and Ryr2 gene expression, thereby demonstrating a possible benefit of T4 treatment for heart function in ESS associated with HF. Conclusion The T4 treatment can potentially normalize the levels of T3 as well elevated Serca2 and Ryr2 gene expression in the myocardium in heart failure rats with euthyroid sick syndrome.


Sujets)
Animaux , Mâle , Thyroxine/administration et posologie , Syndrome euthyroïdien/traitement médicamenteux , Canal de libération du calcium du récepteur à la ryanodine/effets des médicaments et des substances chimiques , Sténose aortique/complications , Thyroxine/usage thérapeutique , Tri-iodothyronine/effets des médicaments et des substances chimiques , Syndrome euthyroïdien/complications , Syndrome euthyroïdien/génétique , ARN messager/métabolisme , Expression des gènes/effets des médicaments et des substances chimiques , Rat Wistar , Canal de libération du calcium du récepteur à la ryanodine/génétique , Modèles animaux , Sarcoplasmic Reticulum Calcium-Transporting ATPases/effets des médicaments et des substances chimiques , Sarcoplasmic Reticulum Calcium-Transporting ATPases/génétique , Défaillance cardiaque/complications
2.
Biol. Res ; 39(1): 189-190, 2006. ilus
Article Dans Anglais | LILACS | ID: lil-430712

Résumé

Recent evidence suggests that reactive oxygen species function as second messenger molecules in normal physiological processes. For example, activation of N-Methyl-D-Aspartate receptor results in the production of ROS, which appears to be critical for synaptic plasticity, one of the cellular mechanisms that underlie learning and memory. In this work, we studied the effect of iron in the activation of MAPK/ERK pathway and on Ca2+ signaling in neuronal PC12 cells. We found that iron-dependent generation of hydroxyl radicals is likely to modulate Ca2+ signaling through RyR calcium channel activation, which, in turn, activates the MAPK/ERK pathway. These findings underline the relevance of iron in normal neuronal function.


Sujets)
Animaux , Rats , Extracellular Signal-Regulated MAP Kinases/effets des médicaments et des substances chimiques , Fer/pharmacologie , Neuroblastome/enzymologie , Espèces réactives de l'oxygène/métabolisme , Canal de libération du calcium du récepteur à la ryanodine/effets des médicaments et des substances chimiques , Technique de Western , Activation enzymatique/effets des médicaments et des substances chimiques , Extracellular Signal-Regulated MAP Kinases/métabolisme , /métabolisme , Phosphorylation/effets des médicaments et des substances chimiques , Canal de libération du calcium du récepteur à la ryanodine/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques
3.
Biol. Res ; 33(2): 113-124, 2000. graf
Article Dans Anglais | LILACS | ID: lil-443671

Résumé

The effects of redox reagents on the activity of the intracellular calcium release channels (ryanodine receptors) of skeletal and cardiac muscle, or brain cortex neurons, was examined. In lipid bilayer experiments, oxidizing agents (2,2'-dithiodipyridine or thimerosal) modified the calcium dependence of all single channels studied. After controlled oxidation channels became active at sub microM calcium concentrations and were not inhibited by increasing the calcium concentration to 0.5 mM. Subsequent reduction reversed these effects. Channels purified from amphibian skeletal muscle exhibited the same behavior, indicating that the SH groups responsible for modifying the calcium dependence belong to the channel protein. Parallel experiments that measured calcium release through these channels in sarcoplasmic reticulum vesicles showed that following oxidation, the channels were no longer inhibited by sub mM concentrations of Mg2+. It is proposed that channel redox state controls the high affinity sites responsible for calcium activation as well as the low affinity sites involved in Mg2+ inhibition of channel activity. The possible physiological and pathological implications of these results are discussed.


Sujets)
Animaux , Lapins , Rats , Canal de libération du calcium du récepteur à la ryanodine/effets des médicaments et des substances chimiques , Thiols/pharmacologie , Cortex cérébral/cytologie , Myocytes cardiaques/métabolisme , Neurones/métabolisme , Réticulum sarcoplasmique/métabolisme , Anura , Canal de libération du calcium du récepteur à la ryanodine/métabolisme , Oxydoréduction
SÉLECTION CITATIONS
Détails de la recherche